𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

✍ Scribed by Donal J. Brennan; Sara Ek; Emma Doyle; Thomas Drew; Michael Foley; Grainne Flannelly; Darran P. O’Connor; William M. Gallagher; Sami Kilpinen; Olli-Pekka Kallioniemi; Karin Jirstrom; Colm O’Herlihy; Carl A.K. Borrebaeck

Book ID
116429972
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
540 KB
Volume
45
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen activator inhibitor-1 is an
Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients
✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB 👁 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

Preoperative serum level of inhibin A is
Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma
✍ Antonio E. Frias Jr.; Honghze Li; Gary L. Keeney; Karl C. Podratz; Teresa K. Woo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: The aim of this study was to determine the prognostic significance of preoperative serum inhibin and activin levels in postmenopausal women with epithelial ovarian carcinoma (eoc) by correlating serum levels with disease parameters, including tumor stage and grade and patient age. #